KIDS
OrthoPediatrics Corp.
NASDAQ · Healthcare · Medical - Devices · US
$22.41
−0.80%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 252.7M | 236.3M | 204.7M | 148.7M | 122.3M |
| Cost of Revenue | 66.6M | 63.7M | 56.1M | 37.5M | 31.6M |
| Gross Profit | 186.1M | 172.7M | 148.6M | 111.3M | 90.7M |
| Operating Expenses | |||||
| R&D Expense | 9.1M | 9.1M | 11.0M | 10.9M | 8.5M |
| SG&A Expense | 199.8M | 192.6M | 167.1M | 126.1M | 104.0M |
| General & Admin Expense | 122.9M | 119.8M | 102.8M | 73.3M | 57.9M |
| Selling & Marketing Expense | 76.8M | 72.7M | 64.3M | 52.8M | 46.1M |
| Other Expenses | 1.0K | — | — | 985.0K | 3.6M |
| Total Operating Expenses | 208.9M | 201.7M | 178.1M | 138.0M | 116.1M |
| Cost and Expenses | 275.5M | 265.3M | 234.2M | 175.5M | 147.7M |
| Operating Income (EBIT) | (22.8M) | (29.0M) | (29.5M) | (26.8M) | (25.4M) |
| Non-Operating | |||||
| Interest Income | — | — | — | 198.0K | — |
| Interest Expense | 8.4M | 6.0M | 2.6M | — | 2.4M |
| Net Interest Income | (8.4M) | (6.0M) | (2.6M) | 198.0K | (2.4M) |
| Other Non-Op Income/Expense | (16.7M) | (10.2M) | (12.4M) | 5.4M | 21.7M |
| Non-Operating Income (excl Interest) | 4.1M | 4.2M | 9.8M | (985.0K) | (3.6M) |
| EBT (Pre-Tax Income) | (39.4M) | (39.2M) | (41.9M) | (21.3M) | (3.7M) |
| Income Tax Expense | 278.0K | 460.0K | (4.1M) | (338.0K) | (4.9M) |
| Bottom Line | |||||
| Net Income | (39.7M) | (39.6M) | (37.8M) | (21.0M) | 1.3M |
| Earnings from Cont. Ops | (39.7M) | (39.6M) | (37.8M) | (21.0M) | 1.3M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (39.7M) | (39.6M) | (37.8M) | (21.0M) | 1.2M |
| Per Share | |||||
| Basic EPS | ($1.68) | ($1.69) | ($1.64) | ($0.92) | $0.06 |
| Diluted EPS | ($1.68) | ($1.69) | ($1.64) | ($0.92) | $0.06 |
| Revenue Per Share | $10.59 | $10.07 | $8.87 | $6.56 | $5.91 |
| Shares | |||||
| Basic Shares Outstanding | 23.9M | 23.5M | 23.1M | 22.7M | 20.7M |
| Diluted Shares Outstanding | 23.9M | 23.5M | 23.1M | 22.7M | 20.9M |
| Profitability Metrics | |||||
| EBITDA | (10.2M) | (11.9M) | (20.2M) | (8.4M) | (8.7M) |
| D&A | 16.6M | 21.2M | 19.1M | 17.4M | 13.1M |
| EBIT | (26.9M) | (33.2M) | (39.3M) | (25.8M) | (21.8M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026